Researchers find a surprising link between certain pollutants and reduced autism risk, the world welcomes — and fears — the first primate clones, and new U.S. clinical trial rules reverberate globally.

Common genetics may help forge social ties, a nonspeaking woman with autism hosts “The Late Show,” and the mix of bacteria in the gut may relate to brain structure.

The male-dominated sex bias in autism is reversed in a related syndrome, a researcher’s gender could influence her study’s outcome, and an award-nominated ad featuring a young man with autism draws criticism.

Autism prevalence plateaued for the years 2014 to 2016, a review finds no evidence that herbal therapies for autism work, and a panel of four proteins in blood may distinguish children with autism.

The advocacy organization Autism Speaks releases its three-year strategic research plan, a new autism journal is slated for 2019, and updated U.S. developmental disability prevalence numbers are published.

A sweeping analysis covers evidence of regression in autism, gender dysphoria is linked to autism features, and animal models of autism receive full treatment in a special tribute.

A pruning protein reshapes neurons, culture should be a consideration in trials of autism treatments, and another U.S. state adds autism to the list of indications for medical cannabis.

Adults on the spectrum explain the problem with eye contact, experts offer tips for students with autism considering college, and men with autism respond differently to the “smell of fear.”

The agency that oversees the drug approval process in Europe is moving to Amsterdam, gene editing gets its first human trial, and a tiny sensor detects even a few oxytocin molecules in blood.

An interview for diagnosing adults on the spectrum clears its first hurdle, a fragile X drug eases multiple features of the syndrome in a mouse model, and a brain bank chronicles the beautiful diversity of neurons.